Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_16-cv-00065/USCOURTS-caed-1_16-cv-00065-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Krista M. Enns, State Bar No. 206430 

Winston & Strawn LLP 

101 California St. 

San Francisco, CA 94111 

Phone: 415.591.1402 

Fax: 415.591.1400 

kenns@winston.com 

Attorney for Defendants 

Otsuka Pharmaceutical Co., Ltd., and 

Otsuka America Pharmaceutical, Inc. 

IN THE UNITED STATES DISTRICT COURT 

FOR THE EASTERN DISTRICT OF CALIFORNIA – FRESNO DIVISION 

BRENDA SEARS and ROBERT SEARS, CASE NO.: 1:16-cv-00065-BAM 

 Plaintiffs, 

 

 v. 

 STIPULATION TO EXTEND TIME AND 

BRISTOL-MYERS SQUIBB COMPANY, ORDER

OTSUKA PHARMACEUTICAL CO., LTD., 

and OTSUKA AMERICA 

PHARMACEUTICAL, INC. 

 Defendants. 

This stipulation in the above-captioned matter is made by and between the attorneys for 

Plaintiffs Brenda Sears and Robert Sears (“Plaintiffs”) and Defendants Bristol-Myers Squibb 

Company, Otsuka Pharmaceutical Co., Ltd., and Otsuka America Pharmaceutical, Inc. (collectively 

“Defendants”). 

IT IS HEREBY STIPULATED AND AGREED, by and between the attorneys for the parties 

hereto, that the prescribed time within which Defendants may move, answer, or otherwise respond to 

the Complaint is hereby extended by 30 days, and that Plaintiffs will have an additional 30 days 

from the time prescribed by the applicable rules to respond to any motion filed by Defendants in 

response to the Complaint. 

Case 1:16-cv-00065-LJO-BAM Document 16 Filed 02/16/16 Page 1 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

This is the parties’ first request for an extension. All parties agree to this extension, and the 

extension does not affect any other previously scheduled dates. 

 IT IS SO STIPULATED. 

Dated: February 12, 2016 

 

 /s/ Barry Thompson 

 Barry Thompson 

 Hogan Lovells US LLP 

 1999 Avenue of the Stars, Suite 1400 

Los Angeles, California 90067 

Telephone: (310) 785-4600 

Fax: (310) 785-4601 

 barry.thompson@hoganlovells.com 

 Lauren Colton 

 Hogan Lovells US LLP 

 100 International Drive, Suite 200 

Baltimore, Maryland 21202 

Telephone: (410) 659-2700 

Fax: (410) 659-2701 

 lauren.colton@hoganlovells.com 

 Attorneys for Defendant Bristol-Myers Squibb 

 Company 

 /s/ Krista M. Enns 

Krista M. Enns, State Bar No. 206430 

Winston & Strawn LLP 

101 California St. 

San Francisco, CA 94111 

Phone: 415.591.1402 

Fax: 415.591.1400 

kenns@winston.com 

Matthew A. Campbell 

Winston & Strawn LLP 

1700 K Street, N.W. 

Washington, DC 20006 

Phone: 202.282.5848 

macampbe@winston.com 

Luke A. Connelly 

Winston & Strawn LLP 

200 Park Avenue 

New York, NY 10166 

Case 1:16-cv-00065-LJO-BAM Document 16 Filed 02/16/16 Page 2 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Phone: 212.294.6882 

lconnell@winston.com 

Attorneys for Defendant 

Otsuka Pharmaceutical Co., Ltd. 

and Otsuka America Pharmaceutical, Inc. 

Dated: February 12, 2016 /s/ Gary L. Wilson 

Gary L. Wilson (CA Bar # 139358) 

Megan J. McKenzie (MN Bar # 388081) 

2800 LaSalle Plaza 

800 LaSalle Avenue 

Minneapolis, MN 55402-2015 

Phone: 612.349.8500 

Fax: 612.339.4181 

gwilson@robinskaplan.com 

mmckenzie@robinskaplan.com 

Attorneys for Plaintiffs Brenda Sears and 

Robert Sears

 ORDERED 

IT IS SO ORDERED THAT the Defendants Bristol-Myers Squibb Company, Otsuka 

Pharmaceutical Co., Ltd., and Otsuka America Pharmaceutical, Inc. (collectively “Defendants”) will 

have an additional 30 days from the time returned Summons for the Defendants (Docs. 11, 12 and 

13), respond to any motion filed by Defendants in response to the Complaint is due by March 17, 

2016. 

Dated: February 16, 2016 /s/ Barbara A. McAuliffe 

 UNITED STATES MAGISTRATE JUDGE 

Case 1:16-cv-00065-LJO-BAM Document 16 Filed 02/16/16 Page 3 of 4
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Case 1:16-cv-00065-LJO-BAM Document 16 Filed 02/16/16 Page 4 of 4